Eastwood Bio-Medical Canada Inc. EBM.V
TSX
| 07/31/2026 | 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 43.49% | 52.43% | 31.13% | 29.22% | 16.98% |
| Total Depreciation and Amortization | -56.37% | -78.82% | -91.75% | -60.00% | -34.18% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 137.29% | 144.44% | -71.43% | -85.71% | -251.28% |
| Change in Net Operating Assets | -48.73% | -43.57% | 2.67% | -5.41% | -2.07% |
| Cash from Operations | -144.97% | 142.42% | 243.06% | 225.45% | 551.52% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 30.48% | 13.83% | 1.14% | -37.91% | -23.36% |
| Total Debt Repaid | -11.00% | -151.49% | -59.76% | 44.09% | 0.20% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 42.86% | -168.46% | -173.42% | 94.44% | -444.44% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -341.18% | -196.88% | 514.29% | 192.47% | 198.08% |